Clinical Trial Update: Phase 1/1b/2 Study of Oral PMD-026 in Patients With Metastatic Breast Cancer [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/1b/2 oral PMD-026 trial in patients with metastatic breast cancer is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• PMD-026

Snippet

Sponsor: Phoenix Molecular Designs | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: RECRUITING